[
    {
        "scene": null,
        "question": {},
        "response": "Final Assessment:\nDisseminated recurrent gynecologic malignancy with progressive pelvic, liver, and probable bone involvement in a non‑curative setting; histologic subtype, primary site, performance status, and anemia etiology remain unresolved. [@2022-12-29|MR; @2022-12-29|CT; @20230103|5600862]\n\nCore Treatment Strategy:\n- Maintain non‑curative, symptom‑focused intent and engage palliative care for pain, bowel/bladder, and liver/bone symptom management.  \n- Urgently evaluate severe anemia (iron/B12/folate, bleeding/hemolysis) and provide transfusion/supportive care before systemic therapy decisions. [@20230103|5600862]  \n- Expedite retrieval/review of all pathology (initial and recurrence histology, IHC, staging) and full prior treatment history; currently unknown.  \n- Defer new systemic treatment intensity and any radiotherapy planning until anemia work‑up, ECOG status, pathology clarification, and patient goals are documented.  \n\nChange Triggers:\n- If anemia stabilized and ECOG acceptable, then revisit suitability and goals of systemic therapy versus best supportive care focus.  \n- If pathology/treatment history clarify primary site and subtype, then individualize systemic and radiotherapy strategies per disease biology and prior exposure.",
        "gold_plan": "可考虑参加临床试验（13916855649/15056967974）或换方案化疗。\n-检验科申请：血常规新(五分类)　肝功能(全套)　肾功能(不含血糖)检查地点：徐汇院区：东安路270号1号楼3楼检验科 。检验科申请：血常规新(五分类)　CA125(肿瘤抗原CA125)　HE4（卵巢癌）　CA15-3(肿瘤抗原CA15-3)检查地点：徐汇院区：东安路270号1号楼3楼检验科 。本科处置：静脉输液×7次　一次性使用精密过滤输液器带针W×7副　动静脉置管护理×7天　BD10ml预充式导管冲洗器×14个西药及中成药方：[甲]氯化钠注射液(百特)　0.9%*250ml×7袋/静滴　1袋/qd　d1-7[乙10%]蔗糖铁注射液(维乐福)　100mg*5ml*5支/盒×21支/静滴　3支/qd　d1-7[甲]氯化钠针(百特塑袋)　100ml*0.9%×7袋/静滴　1袋/qd　d1-7。本科处置：静脉输液×7次　一次性使用精密过滤输液器带针W×7副　动静脉置管护理×7天　BD10ml预充式导管冲洗器×14个西药及中成药方：※[乙0%]人促红素注射液(益比奥)　10000IU×3支/皮下　1支/qod　d1,3,5。本科处置：肌肉注射×3次",
        "question_raw": null,
        "Time": "2023-01-03 08:53:29.260000",
        "meta_info": "340123197709263626"
    }
]